CLINICAL ROLE -
First Biosimilar Filgrastim Launched Today
The first biosimilar to receive FDA approval is now available the United States.
Read More
Second PCSK9 Repatha Approved by FDA
The FDA today approved evolocumab (Repatha) injection, a new treatment for patients unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options.